SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-030406
Filing Date
2014-05-14
Accepted
2014-05-14 16:00:40
Documents
4
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v378119_10q.htm 10-Q 579157
2 EXHIBIT 31.1 v378119_ex31-1.htm EX-31.1 8869
3 EXHIBIT 31.2 v378119_ex31-2.htm EX-31.2 9006
4 EXHIBIT 32.1 v378119_ex32-1.htm EX-32.1 4215
  Complete submission text file 0001144204-14-030406.txt   602297
Mailing Address 600 W. GERMANTOWN PIKE SUITE 400 PLYMOUTH MEETING PA 19462
Business Address 600 W. GERMANTOWN PIKE SUITE 400 PLYMOUTH MEETING PA 19462 610-771-0680
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-193455 | Film No.: 14841428
SIC: 2834 Pharmaceutical Preparations